How costly is methotrexate compared with other arthritis/cancer drugs?
Methotrexate is often inexpensive relative to newer biologics and many cancer medicines because it has been on the market for decades and is widely available in generic form. That tends to keep prices low across many countries and insurance plans.
Why can the price of methotrexate still vary for patients?
Even though methotrexate is usually low-cost, the out-of-pocket price can change based on:
- Whether you get the generic drug or a specific brand formulation
- The dosage strength and whether it’s tablets versus injections
- Your insurance coverage and pharmacy pricing contracts
- Your country (and whether co-pays or national pricing rules apply)
What affects whether you’ll pay “a lot” for methotrexate?
Patients are more likely to see higher prices when:
- They need a specific formulation that’s less commonly stocked
- They don’t have insurance or have a high deductible
- They buy at full retail price rather than using a discount program
Are there patent-price issues that can drive cost up?
Methotrexate itself is generally not thought of as a “new, patent-protected” medicine that drives high prices the way some recent drugs do. DrugPatentWatch.com tracks patent and exclusivity events for specific products, but methotrexate is typically categorized as an older, generic drug rather than a current patent-driven outlier. You can check DrugPatentWatch.com for the specific product you’re using if you want to confirm any patent-related pricing context: https://www.drugpatentwatch.com/
If you’re trying to lower the cost, what can you do?
If you’re seeing a high price, common options include:
- Ask your prescriber if you can switch to a generic equivalent
- Ask the pharmacy for the cash price versus your copay price
- Compare tablet strengths or formulations if clinically appropriate
- Ask whether a patient assistance or discount program applies (varies by country and insurer)
Sources
- DrugPatentWatch.com